ScholarIQanswers from OpenAlex & ORCID
Orlando M. Gutiérrez
ResearcherPublications, citations & collaboration network
Orlando M. Gutiérrez is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Orlando M. Gutiérrez have?
ScholarIQindexed works
Orlando M. Gutiérrez has 382 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Orlando M. Gutiérrez have?
ScholarIQcitation count
Orlando M. Gutiérrez has 20,269 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Orlando M. Gutiérrez?
ScholarIQh-index
Orlando M. Gutiérrez has an h-index of 65 in OpenAlex.
What is the i10-index of Orlando M. Gutiérrez?
ScholarIQi10-index
Orlando M. Gutiérrez has an i10-index of 179 in OpenAlex.
What is the ORCID of Orlando M. Gutiérrez?
ScholarIQorcid
The ORCID for Orlando M. Gutiérrez is on the source record.
What is the OpenAlex record for Orlando M. Gutiérrez?
ScholarIQopenalex
The OpenAlex for Orlando M. Gutiérrez is on the source record.
What are the most-cited papers on Orlando M. Gutiérrez?
ScholarIQmost cited works
FGF23 induces left ventricular hypertrophy
Christian Faul, Ansel P. Amaral, Behzad N. Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mündel, Azorides R. Morales, Julia J. Scialla, Michael J. Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal A. Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro‐o, John W. Kusek, Martin Keane, Myles Wolf
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova, on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Patricia Wahl, Gabriela Vargas, Orlando M. Gutiérrez, Julia J. Scialla, Huiliang Xie, Dina Appleby, Lisa Nessel, Keith Bellovich, Jing Chen, L. Lee Hamm, Crystal A. Gadegbeku, Edward Horwitz, Raymond R. Townsend, Cheryl A.M. Anderson, James P. Lash, Chi‐yuan Hsu, Mary B. Leonard, Myles Wolf
Development and Validation of the American Heart Association’s PREVENT Equations
Sadiya S. Khan, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Aditya Surapaneni, Michael J. Blaha, April P. Carson, Alex R. Chang, Elizabeth L. Ciemins, Alan S. Go, Orlando M. Gutiérrez, Shih‐Jen Hwang, Simerjot K Jassal, Csaba P. Kövesdy, Donald M. Lloyd‐Jones, Michael G. Shlipak, Latha Palaniappan, Laurence Sperling, Salim S. Virani, Katherine R. Tuttle, Ian J. Neeland, Sheryl L. Chow, Janani Rangaswami, Michael Pencina, Chiadi E. Ndumele, Josef Coresh
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutiérrez, James L. Januzzi, Tamara Isakova, Karen Laliberte, Kelsey Smith, Gina Collerone, Ammar Sarwar, Udo Hoffmann, Erin Coglianese, Robert H. Christenson, Thomas J. Wang, Christopher R. deFilippi, Myles Wolf
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Tamara Isakova, Thomas L. Nickolas, Michelle Denburg, Sri G. Yarlagadda, Daniel E. Weiner, Orlando M. Gutiérrez, Vinod Bansal, Sylvia E. Rosas, Sagar U. Nigwekar, Jerry Yee, Holly Kramer